Special Feature

User Panel

My Panel

My Panel

Bookmark Science Articles

Recent News
Bookmark / Share This Science Site

Treatment with amisulpride and olanzapine improve neuropsychological function in schizophrenia.

Treatment with amisulpride and olanzapine improve neuropsychological function in schizophrenia. Research Abstract Details 

Research Abstract Table of Contents

Jump to the:

  • Abstract Text of This Paper
  • Journal Published
  • MeSH Keywords of This Abstract
  • Chemicals and Substances Used in this Paper
  • Grants and Granting Agency of this Research
  • Database Accession Numbers Used in this Paper
  • Related Papers
  • Related Research Tags
  • Rate this Research Paper
  • Treatment with amisulpride and olanzapine improve neuropsychological function in schizophrenia. Abstract Text:

    ann m mortimerAnn M Mortimer,eileen joyceEileen Joyce,krishnapillai balasubramaniamKrishnapillai Balasubramaniam,prasoon c choudharyPrasoon C Choudhary,packeeruther t saleemPackeeruther T Saleem, ,ann m mortimerAnn M Mortimer,eileen joyceEileen Joyce,krishnapillai balasubramaniamKrishnapillai Balasubramaniam,prasoon c choudharyPrasoon C Choudhary,packeeruther t saleemPackeeruther T Saleem, ,

    OBJECTIVES: Although antipsychotic drugs control acute psychotic manifestations of schizophrenia, improving cognitive symptoms is also important for long-term prognosis. METHODS: Three hundred and seventy-seven adult patients with acute psychosis were randomised to either amisulpride (200-800 mg/d) or olanzapine (5-20 mg/d) for 6 months. Neuropsychological performance was assessed at inclusion and after 6 months in a subgroup of 26 subjects (11 treated with amisulpride and 15 with olanzapine) using the Auditory Verbal Learning Test (AVLT), the Trail Making Test (TMT) and the Controlled Oral Word Association Test (COWAT). RESULTS: The improvement in BPRS score was similar in both treatment groups. No significant differences in test performance between groups were observed at inclusion. After 6 months, AVLT scores increased by 8.7 points in the amisulpride group and by 2.3 points in the olanzapine group (p = 0.049). Completion speed in the TMT increased by 17.4 s (amisulpride) and 15.4 s (olanzapine) for Part A and by 39.8 and 48.8 s, respectively for Part B. Performance in the COWAT improved little in both groups. CONCLUSIONS: Both amisulpride and olanzapine produce sustained improvement in certain measures of neuropsychological performance in patients with schizophrenia; a significant improvement in score on the AVLT was observed only with amisulpride.

    Treatment with amisulpride and olanzapine improve neuropsychological function in schizophrenia. Publishing Authors By Initials

    am mortimerAM Mortimer,e joyceE Joyce,k balasubramaniamK Balasubramaniam,pc choudharyPC Choudhary,pt saleemPT Saleem, ,am mortimerAM Mortimer,e joyceE Joyce,k balasubramaniamK Balasubramaniam,pc choudharyPC Choudhary,pt saleemPT Saleem, ,

    For similar abstracts research abstracts see: abstracts research

    PUBMED ID PMID:

    MEDLINE DATE:

    Treatment with amisulpride and olanzapine improve neuropsychological function in schizophrenia. Journal Published:

    PUBLICATION TYPE: Research Support, Non-U.S. Gov

    Journal: Human psychopharmacology

    VOLUME: 22

    Page Numbers: 445-54

    Journal Abbreviation:

    ISSN: 0885-6222

    DAY: 1

    MONTH: Oct

    YEAR: 2007

    Treatment with amisulpride and olanzapine improve neuropsychological function in schizophrenia. Information

    Number of References:

    LANGUAGE: eng

    NlmUniqueID: 8702539

    Treatment with amisulpride and olanzapine improve neuropsychological function in schizophrenia. Keywords Mesh Terms:

    KEYWORDS:

    MESH TERMS:

    Chemical & Substance for Abstract: Treatment with amisulpride and olanzapine improve neuropsychological function in schizophrenia. Information

    Substance Name:

    Registry Number:

    Grant and Affiliation Information for Treatment with amisulpride and olanzapine improve neuropsychological function in schizophrenia.

    AFFILIATION: University of Hull, Hull, UK. A.M.Mortimer@hull.ac.uk

    Country: England

    England Research PublicationEngland Research Publication

    AGENCY:

    GRANT:

    ACRONYM:

    MEDLINETA: Hum Psychopharmacol

    REFSOURCE:

    DATABASENAME:

    ACCESSION NUMBER:

    Number Hits: 0

    Treatment with amisulpride and olanzapine improve neuropsychological function in schizophrenia Related Publications

     

    Molecular Station USER Menu

    Welcome to Molecular Station!

    You have to register before you can post on our forums or use our advanced features. Register Now! Its Free and Fast!

    Already registered? Login now below.

    User Name:

    Password:

    Already registered and Forgot your password? Click below to recover it.

    Recover Lost Password

    Join now - it's fast and free!

    Molecular Station is THE largest network of researchers, scientists and science lovers anywhere!

    Research Terms of Usage and Disclaimer
    Home
    Features

    Protocols

    DNA Forum

    Science Forum

    DNA Forum
    Biology Forum

    Science News


    [CaRP] XML error: Invalid document end at line 2

    For more click here:Science News